Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Cancer Policy|February 28, 2026
Do U.S. Cancer Drug Sales Reflect Clinical Benefit? Evidence from Solid Tumor Drugs from 2008 to 2022Melissa Miri, Sumaya Abuloha, Shu Niu, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 9, 2021
Anti-inflammatory action of betulin and its potential as a dissociated glucocorticoid receptor modulatorLi Ren, Shu Niu, Yantong Sun, et al.
Open Medicine (Warsaw, Poland)|February 24, 2025
Corrigendum to "Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism"Lin Yue, Yue Wang, Cuiying Wang, et al.
The Science of the Total Environment|August 24, 2020
Facile synthesis and synergistic mechanism of CoFe2O4@three-dimensional graphene aerogels towards peroxymonosulfate activation for highly efficient degradation of recalcitrant organic pollutantsXinran Li, Zhehua Liu, Yongjuan Zhu, et al.
Open Medicine (Warsaw, Poland)|August 23, 2024
Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolismLin Yue, Yue Wang, Cuiying Wang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 5, 2023
Mechanisms of Small Intestine Involvement in Obesity-Induced AtherosclerosisXiaoyu Pan, Zhuoya Jia, Ruoxi Zhen, et al.
Frontiers in Endocrinology|October 17, 2025
Multi-omics analysis of hepatic outcomes in T2DM-MAFLD patients treated with semaglutide: a single-centre, longitudinal, data-driven studyShu Niu, Shuchun Chen, Di Wu, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 30, 2023
Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver MiceShu Niu, Qingjuan Ren, Shuchun Chen, et al.
Drug Design, Development and Therapy|October 28, 2022
An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle MetabolismQingjuan Ren, Shuchun Chen, Xing Chen, et al.
Frontiers in Endocrinology|November 24, 2022
Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese miceLin Yue, Shuchun Chen, Qingjuan Ren, et al.
Pageof 6